"Peptide Puzzle: Why Overseas Labs Dominate the US Market, Despite FDA Ban In a seemingly paradoxical situation, the US Food and Drug Administration (FDA) has imposed a ban on most peptides, a class of compounds that have potential therapeutic benefits. However, this restriction has led to a market dominated by products from overseas labs, sparking concerns about the safety and efficacy of these imports. As the FDA seeks to protect American consumers, critics argue that the ban has inadvertently created a regulatory vacuum, allowing foreign manufacturers to fill the gap. But do these imported peptides truly safeguard public health, or is this a case of regulatory overreach?"
Because the agency has banned most peptides, products from overseas labs dominate the market. How does that protect Americans?
